These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7817200)

  • 1. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
    Neal CE; Meis LC
    Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in ovarian and prostate cancer.
    Neal CE; Swenson LC; Fanning J; Texter JH
    Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
    Neal CE; Johnson DL; Cornwell VL; Markwell S
    Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capromab Pendetide imaging of prostate cancer.
    Haseman MK; Rosenthal SA; Polascik TJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.
    Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD
    Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
    Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
    Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.
    Liehn JC; Loboguerrero A; Pérault C; Demange L
    Eur J Nucl Med; 1992; 19(3):186-94. PubMed ID: 1572383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies.
    Nabi HA; Erb DA; Cronin VR
    Nucl Med Commun; 1995 Aug; 16(8):631-9. PubMed ID: 7491174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer. Radiologic staging.
    Thoeni RF
    Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management.
    Corman ML; Galandiuk S; Block GE; Prager ED; Weiner GJ; Kahn D; Abdel-Nabi H; Mitchell EP; Pascucci VL; Maroli AN
    Dis Colon Rectum; 1994 Feb; 37(2):129-37. PubMed ID: 8306832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.
    Wolff BG; Bolton J; Baum R; Chetanneau A; Pecking A; Serafini AN; Fischman AJ; Hoover HC; Klein JL; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    Dis Colon Rectum; 1998 Aug; 41(8):953-62. PubMed ID: 9715149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoguided surgery.
    Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
    Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients.
    Abdel-Nabi H; Doerr RJ
    Semin Nucl Med; 1993 Apr; 23(2):99-113. PubMed ID: 8511606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
    Markowitz A; Saleemi K; Freeman LM
    Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.